Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hermann Wagner

Showing results (241-250 of 248) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 248 results.
Cell Reports|October 21, 2016
Conventional Dendritic Cells Confer Protection against Mouse Cytomegalovirus Infection via TLR9 and MyD88 SignalingFranz Puttur, Marcela Francozo, Gülhas Solmaz, et al.
Science (New York, N.Y.)|July 24, 2012
TLR13 recognizes bacterial 23S rRNA devoid of erythromycin resistance-forming modificationMarina Oldenburg, Anne Krüger, Ruth Ferstl, et al.
The Journal of Experimental Medicine|December 10, 2008
Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLEVilma Urbonaviciute, Barbara G Fürnrohr, Silke Meister, et al.
The Journal of Experimental Medicine|January 14, 2009
Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRgamma-Syk-Card9-dependent innate immune activationKerstin Werninghaus, Anna Babiak, Olaf Gross, et al.
The Journal of Experimental Medicine|December 10, 2009
Maternal TLR signaling is required for prenatal asthma protection by the nonpathogenic microbe Acinetobacter lwoffii F78Melanie L Conrad, Ruth Ferstl, René Teich, et al.
European Journal of Immunology|December 3, 2005
Systemic application of CpG-rich DNA suppresses adaptive T cell immunity via induction of IDOGerhard Wingender, Natalio Garbi, Beatrix Schumak, et al.
Immunity|April 23, 2005
Autoimmunity and inflammation due to a gain-of-function mutation in phospholipase C gamma 2 that specifically increases external Ca2+ entryPhilipp Yu, Rainer Constien, Neil Dear, et al.
Oncotarget|December 25, 2014
Classification of current anticancer immunotherapiesLorenzo Galluzzi, Erika Vacchelli, José-Manuel Bravo-San Pedro, et al.
Pageof 25

Showing results (241-250 of 248) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 248 results.
Cell Reports|October 21, 2016
Conventional Dendritic Cells Confer Protection against Mouse Cytomegalovirus Infection via TLR9 and MyD88 SignalingFranz Puttur, Marcela Francozo, Gülhas Solmaz, et al.
Science (New York, N.Y.)|July 24, 2012
TLR13 recognizes bacterial 23S rRNA devoid of erythromycin resistance-forming modificationMarina Oldenburg, Anne Krüger, Ruth Ferstl, et al.
The Journal of Experimental Medicine|December 10, 2008
Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLEVilma Urbonaviciute, Barbara G Fürnrohr, Silke Meister, et al.
The Journal of Experimental Medicine|January 14, 2009
Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRgamma-Syk-Card9-dependent innate immune activationKerstin Werninghaus, Anna Babiak, Olaf Gross, et al.
The Journal of Experimental Medicine|December 10, 2009
Maternal TLR signaling is required for prenatal asthma protection by the nonpathogenic microbe Acinetobacter lwoffii F78Melanie L Conrad, Ruth Ferstl, René Teich, et al.
European Journal of Immunology|December 3, 2005
Systemic application of CpG-rich DNA suppresses adaptive T cell immunity via induction of IDOGerhard Wingender, Natalio Garbi, Beatrix Schumak, et al.
Immunity|April 23, 2005
Autoimmunity and inflammation due to a gain-of-function mutation in phospholipase C gamma 2 that specifically increases external Ca2+ entryPhilipp Yu, Rainer Constien, Neil Dear, et al.
Oncotarget|December 25, 2014
Classification of current anticancer immunotherapiesLorenzo Galluzzi, Erika Vacchelli, José-Manuel Bravo-San Pedro, et al.
Pageof 25